secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENET HEALTHCARE CORP (THC)
CIK:        0000070318
Form:       8-K
Filed at:   2022-10-20T23:59:59+00:00
Accession:  0000070318-22-000047
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenet Q3 net income $131M, adj EPS $1.44; announces $1B buyback; FY22 EBITDA outlook narrowed
--------------------------------------------------------------------------------

- Q3 net income from continuing ops $131M ($1.16 diluted EPS); adjusted diluted EPS $1.44.
- Consolidated Adj. EBITDA $841M vs $855M in Q3 2021; USPI (ambulatory) EBITDA up 16.4% to $319M.
- Board authorized $1B share repurchase program expiring Dec 31, 2024.
- FY2022 Adj. EBITDA outlook revised to $3.375-$3.475B, ~1% change at midpoint.
- Repaid $880M Medicare advances; free cash flow $190M in 9 months (excl. advances $1.07B).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70318/000007031822000047/0000070318-22-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70318/000007031822000047/thc-20221020.htm
  HTML page:      https://secwatch.observer/filing/0000070318-22-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer